Policy for Classifying Medicines Into Therapeutic Classes for Purposes of Therapeutic Interchange 2021

Policy for Classifying Medicines Into Therapeutic Classes for Purposes of Therapeutic Interchange 2021

The purpose of this policy is to provide guidance for the placement of medicines in therapeutic classes to support therapeutic interchange for purposes of procurement, prescribing, and providing alternatives for prescribers in the case of challenges to medicine access and supply.

Scope

  • This policy is applicable at national, provincial, district and facility levels.
  • This policy relates to the placement of medicines into therapeutic classes and the therapeutic interchange of medicines in such classes.
  • This policy does not relate to generic substitution as provided for in the Medicines and Related Substances Act (Act 101 of 1965) or to therapeutic interchange by a pharmacist or other person dispensing a prescription, which is not provided for in South African legislation (Refer Section 6: Legislative provisions).

Objective
The objective of this policy is to outline:

  • Allocation of medicine into therapeutic classes;
  • Responsibilities for implementation of therapeutic interchange;
  • Conditions under which therapeutic interchange can take place.
Type
Policies
Topic
Therapeutic Interchange
Language
English
Publisher
National Department of Health
Year
2021